Randomised-crossover clinical trial on the substantivity of a single application of a gel containing chlorhexidine and o-cymen-5-ol on the oral biofilm and saliva

dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Cirurxía e Especialidades Médico-Cirúrxicas
dc.contributor.affiliationUniversidade de Santiago de Compostela. Centro de Investigación en Tecnoloxías Intelixentes da USC (CiTIUS)
dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Electrónica e Computación
dc.contributor.authorSuárez Rodríguez, Berta
dc.contributor.authorRegueira Iglesias, Alba
dc.contributor.authorBlanco Pintos, Triana
dc.contributor.authorSánchez Barco, Alba
dc.contributor.authorVila Blanco, Nicolás
dc.contributor.authorBalsa Castro, Carlos
dc.contributor.authorCarreira Nouche, María José
dc.contributor.authorTomás Carmona, Inmaculada
dc.date.accessioned2025-04-23T08:16:11Z
dc.date.available2025-04-23T08:16:11Z
dc.date.issued2024-10-19
dc.description.abstractBackground: No clinical trials have evaluated the antimicrobial activity and substantivity of gel formulations containing chlorhexidine (CHX) and cymenol. Objective: To compare the in situ antimicrobial effect and substantivity of a new 0.20% CHX + cymenol gel (test) with the current 0.20% CHX gel formulation (control) on salivary flora and dental plaque biofilm up to seven hours after a single application. Methods: A randomised-crossover clinical trial was conducted with 29 orally healthy volunteers participating in the development of Experiments 1 (saliva) and 2 (dental plaque biofilm). All subjects participated in both experiments and were randomly assigned to receive either the test or control gels. Samples were collected at baseline and five minutes and one, three, five, and seven hours after a single application of the products. The specimens were processed using confocal laser scanning microscopy after staining with the LIVE/DEAD® BacLight™ solution. Bacterial viability (BV) was quantified in the saliva and biofilm samples. The BV was calculated using the DenTiUS Biofilm software. Results: In Experiment 1, the mean baseline BV was significantly reduced five minutes after application in the test group (87.00% vs. 26.50%; p < 0.01). This effect was maintained throughout all sampling times and continued up to seven hours (40.40%, p < 0.01). The CHX control followed the same pattern. In Experiment 2, the mean baseline BV was also significantly lower five minutes after applying the test gel for: (1) the total thickness of biofilm (91.00% vs. 5.80%; p < 0.01); (2) the upper layer (91.29% vs. 3.94%; p < 0.01); and (3) the lower layer (86.29% vs. 3.83%; p < 0.01). The reduction of BV from baseline was observed for the full-thickness and by layers at all sampling moments and continued seven hours after application (21.30%, 24.13%, and 22.06%, respectively; p < 0.01). Again, the control group showed similar results. No significant differences between test and control gels were observed in either saliva or dental plaque biofilm at any sampling time. Conclusions: A 0.20% CHX + cymenol gel application demonstrates potent and immediate antimicrobial activity on salivary flora and de novo biofilm. This effect is maintained seven hours after application. Similar effects are obtained with a 0.20% CHX-only gel.
dc.description.peerreviewedSI
dc.description.sponsorshipThis research was funded by Grant 2021-CE161 awarded by Lacer, S.A. The funders were not involved in collecting and analysing the data or interpreting the results obtained. This work has also received support from the Xunta de Galicia - Consellería de Cultura, Educación, Formación Profesional e Universidades (accreditation Galician Research Center 2024–2027 ED431G-2023/04 and accreditation Competitive Reference Group 2021–2024, GRC2021/48) and from the European Union (European Regional Development Fund - ERDF).
dc.identifier.citationSuárez-Rodríguez, B., Regueira-Iglesias, A., Blanco-Pintos, T. et al. Randomised-crossover clinical trial on the substantivity of a single application of a gel containing chlorhexidine and o-cymen-5-ol on the oral biofilm and saliva. BMC Oral Health 24, 1247 (2024). https://doi.org/10.1186/s12903-024-05042-7
dc.identifier.doi10.1186/s12903-024-05042-7
dc.identifier.urihttps://hdl.handle.net/10347/40978
dc.issue.number1
dc.journal.titleBMC Oral Health
dc.language.isoeng
dc.publisherBMC
dc.relation.publisherversionhttps://doi.org/10.1186/s12903-024-05042-7
dc.rights© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectChlorhexidine
dc.subjectCymenol
dc.subjectGel
dc.subjectSaliva
dc.subjectOral biofilm
dc.subjectConfocal laser scanning microscopy
dc.subjectBacterial viability
dc.subjectAutomated computation
dc.titleRandomised-crossover clinical trial on the substantivity of a single application of a gel containing chlorhexidine and o-cymen-5-ol on the oral biofilm and saliva
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number24
dspace.entity.typePublication
relation.isAuthorOfPublication5cd58015-b2e7-479a-afe0-4d8b4a7594ff
relation.isAuthorOfPublicationae4a3069-83f6-4a74-8d81-74e238645db9
relation.isAuthorOfPublication8db3b8ef-a488-4815-9722-fd8c2dae8265
relation.isAuthorOfPublicationf9cb8fca-ac19-4df5-819b-5a2dcf6ce966
relation.isAuthorOfPublication.latestForDiscovery5cd58015-b2e7-479a-afe0-4d8b4a7594ff

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2024_bmc-oh_vila-blanco_randomised-crossover.pdf
Size:
5.03 MB
Format:
Adobe Portable Document Format